Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
Whole Transcriptome Sequencing (WTS) is a comprehensive alternative to targeted panels for detecting gene fusions and splice variants. To integrate WTS into clinical diagnostics, we compared its performance against established fusion assays (Archer FusionPlex and TSO500 RNA).
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
05 April 2026
|
| In: |
British journal of cancer
Year: 2026, Volume: 134, Issue: 7, Pages: 1101-1110 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/s41416-025-03307-8 |
| Online Access: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1038/s41416-025-03307-8 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41416-025-03307-8 |
| Author Notes: | Markus Ball, Susanne Beck, Darius Wlochowitz, Tina Fuchs, Katja Lorenz, Christiane Zgorzelski, Alejandro Pallares Robles, Michael Allgäuer, Anna-Lena Volckmar, Hannah Goldschmid, Iordanis Ourailidis, Regine Brandt, Petros Christopoulos, Michael Thomas, Huriye Seker-Cin, Annette Fink, Fabian Schnecko, Olaf Neumann, Michael Menzel, Martina Kirchner, Thoas Fioretos, Peter Schirmacher, Solange Peters, Jan Budczies, Albrecht Stenzinger and Daniel Kazdal |
| Summary: | Whole Transcriptome Sequencing (WTS) is a comprehensive alternative to targeted panels for detecting gene fusions and splice variants. To integrate WTS into clinical diagnostics, we compared its performance against established fusion assays (Archer FusionPlex and TSO500 RNA). |
|---|---|
| Item Description: | Online verfügbar: 14. Januar 2026 Gesehen am 07.05.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/s41416-025-03307-8 |